First Time Loading...
G

Genfit SA
PAR:GNFT

Watchlist Manager
Genfit SA
PAR:GNFT
Watchlist
Price: 3.35 EUR 2.13% Market Closed
Updated: May 8, 2024

Wall Street
Price Targets

GNFT Price Targets Summary
Genfit SA

Wall Street analysts forecast GNFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNFT is 9.49 EUR with a low forecast of 7.07 EUR and a high forecast of 12.08 EUR.

Lowest
Price Target
7.07 EUR
111% Upside
Average
Price Target
9.49 EUR
183% Upside
Highest
Price Target
12.08 EUR
260% Upside
Genfit SA Competitors:
Price Targets
RPTX
Repare Therapeutics Inc
308% Upside
SRZN
Surrozen Inc
238% Upside
DTIL
Precision BioSciences Inc
201% Upside
STOK
Stoke Therapeutics Inc
101% Upside
NTLA
Intellia Therapeutics Inc
213% Upside
049960
Cell Biotech Co Ltd
364% Upside
DCPH
Deciphera Pharmaceuticals Inc
6% Upside
ASND
Ascendis Pharma A/S
36% Upside

Revenue
Forecast

Revenue Estimate
Genfit SA

For the last 8 years the compound annual growth rate for Genfit SA's revenue is 31%. The projected CAGR for the next 3 years is 22%.

31%
Past Growth
22%
Estimated Growth
Estimates Accuracy
24%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genfit SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Genfit SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GNFT's stock price target?
Price Target
9.49 EUR

According to Wall Street analysts, the average 1-year price target for GNFT is 9.49 EUR with a low forecast of 7.07 EUR and a high forecast of 12.08 EUR.

What is Genfit SA's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Genfit SA's revenue is 31%. The projected CAGR for the next 3 years is 22%.